Table 2.
Effects of multiple variables on clinical outcomes in univariate and multivariate analysis
| Univariate analysis | Multivariate analysis* | |||||
| OR | 95% CI | P value | OR | 95% CI | P value | |
| NT-pro-BNP per 100 pg/mL increase | 1.007 | 1.006 to 1.008 | <0.001 | |||
| ALBI as a continuous variable | ||||||
| ALBI, per 0.1 score increase | 1.135 | 1.108 to 1.163 | <0.001 | 1.082 | 1.052 to 1.114 | <0.001 |
| ALBI as a categories variable | ||||||
| Tertile 1 | Reference | Reference | ||||
| Tertile 2 | 1.167 | 0.839 to 1.624 | 0.358 | 0.863 | 0.612 to 1.212 | 0.398 |
| Tertile 3 | 3.082 | 2.326 to 4.084 | <0.001 | 1.671 | 1.228 to 2.274 | 0.001 |
*Adjusted for age, sex, NYHA grading, heart rate on admission, SBP on admission, SGPT, SGOT, LDL, creatinine, haemoglobin, serum Na, FBG, cTNI, LVEF, CHD, hypertension, AF, DM, smoking.
AF, atrial fibrillation; ALBI, albumin-bilirubin; CHD, coronary heart disease; cTNI, cardiac troponin I; DM, diabetes mellitus; FBG, fasting blood glucose; LDL, low-density lipoprotein; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; SBP, stylostic blood pressure; SGOT, serum glutamic oxaloacetic transaminase; SGPT, serum glutamate-pyruvate transaminase.